Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Fink

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Critical Care Medicine|September 17, 2015
Integrated Critical Care Organizations: A Personal ViewMitchell P Fink
Current Opinion in Clinical Nutrition and Metabolic Care|February 15, 2002
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solutionMitchell P Fink
Critical Care Medicine|August 24, 2007
Administration of exogenous cytochrome c as a novel approach for the treatment of cytopathic hypoxiaMitchell P Fink
Critical Care (London, England)|December 21, 2002
Bench-to-bedside review: Cytopathic hypoxiaMitchell P Fink
Virulence|September 12, 2013
Animal models of sepsisMitchell P Fink
The American Journal of Pathology|April 12, 2008
Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsisMitchell P Fink
Critical Care Medicine|March 1, 2006
The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug?Mitchell P Fink
Current Opinion in Critical Care|March 27, 2003
Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illnessMitchell P Fink
Critical Care Medicine|September 23, 2003
Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?Mitchell P Fink
Current Opinion in Critical Care|July 20, 2004
Research: advances in cell biology relevant to critical illnessMitchell P Fink
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Critical Care Medicine|September 17, 2015
Integrated Critical Care Organizations: A Personal ViewMitchell P Fink
Current Opinion in Clinical Nutrition and Metabolic Care|February 15, 2002
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solutionMitchell P Fink
Critical Care Medicine|August 24, 2007
Administration of exogenous cytochrome c as a novel approach for the treatment of cytopathic hypoxiaMitchell P Fink
Critical Care (London, England)|December 21, 2002
Bench-to-bedside review: Cytopathic hypoxiaMitchell P Fink
Virulence|September 12, 2013
Animal models of sepsisMitchell P Fink
The American Journal of Pathology|April 12, 2008
Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsisMitchell P Fink
Critical Care Medicine|March 1, 2006
The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug?Mitchell P Fink
Current Opinion in Critical Care|March 27, 2003
Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illnessMitchell P Fink
Critical Care Medicine|September 23, 2003
Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?Mitchell P Fink
Current Opinion in Critical Care|July 20, 2004
Research: advances in cell biology relevant to critical illnessMitchell P Fink
Pageof 15